TITLE

Is there any relationship between plasma antioxidant capacity and lung function in smokers and in patients with chronic obstructive pulmonary disease?

AUTHOR(S)
Rahman, Irfan; Swarska, Elzbieta; Henry, Michael; Stolk, Jan; MacNee, William
PUB. DATE
March 2000
SOURCE
Thorax;Mar2000, p189
SOURCE TYPE
Review
DOC. TYPE
Book Review
ABSTRACT
No abstract available.
ACCESSION #
66877270

 

Related Articles

  • CORRECTION.  // Thorax;Aug2008, Vol. 63 Issue 8, p753 

    A correction to the article "Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease" in a previous issue is presented.

  • Oxidative Stress in COPD Patients, Smokers, and Non-smokers. Tavilani, Heidar; Nadi, Ebrahim; Karimi, Jamshid; Taghi Goodarzi, Mohammad // Respiratory Care;Dec2012, Vol. 57 Issue 12, p2090 

    BACKGROUND: Oxidative stress has been known for having a key role in pathogenesis of many diseases. The aim of this study was to investigate the oxidative stress and also the relationship between antioxidant system statuses and lung function in patients with COPD and smokers and non-smokers...

  • Erratum to: Proteomic biomarkers in plasma that differentiate rapid and slow decline in lung function in adult cigarette smokers with chronic obstructive pulmonary disease (COPD). Rana, Gaurav; York, Timothy; Edmiston, Jeffery; Zedler, Barbara; Pounds, Joel; Adkins, Joshua; Varnum, Susan; Smith, Richard; Liu, Zaigang; Li, Guoya; Webb, Bradley; Murrelle, Edward; Flora, Jason // Analytical & Bioanalytical Chemistry;Sep2010, Vol. 398 Issue 2, p1133 

    A correction to the article "Proteomic Biomarkers in Plasma That Differentiate Rapid and Slow Decline in Lung Function in Adult Cigarette Smokers With Chronic Obstructive Pulmonary Disease (COPD)" that was published online on July 21, 2010 is presented.

  • Predicting individual lung-function trajectories: An opportunity for prevention? Puhan, Milo A. // CMAJ: Canadian Medical Association Journal;10/4/2016, Vol. 188 Issue 14, p997 

    The author discusses the prediction model developed by Z. Zafari and colleagues to predict lung-function trajectories in individual patients and its effectiveness in the prevention and early treatment of chronic obstructive pulmonary disease (COPD). He says that the prediction tool can be used...

  • Does screening for loss of lung function help smokers give up? Wells, Sally; de Lusignan, Simon // British Journal of Nursing;6/26/2003, Vol. 12 Issue 12, p744 

    Investigates the feasibility of having practice nurses screen smokers for accelerated decline in lung function, with the aim of identifying those at risk of developing chronic obstructive pulmonary disease. Screening for signs of respiratory decline; Data suggesting that screening smokers for...

  • PREŽIVLJAVANJE OBOLELIH OD HRONIÄŒNE OPSTRUKTIVNE BOLESTI PLUĆA U TERMINALNOM STADIJUMU BOLESTI U ZAVISNOSTI OD NAVIKE PUÅ ENJA. Tot Vereš, Kristina // Medicinski Pregled / Medical Review;Mar/Apr2012, Vol. 65 Issue 3/4, p146 

    Introduction Chronic obstructive pulmonary disease is estimated to become the fifth leading cause of death worldwide by 2020. The mortality and morbidity from chronic obstructive pulmonary disease is getting higher and higher as a result of the epidemics in tobacco consumption all over the...

  • Soluble receptor for advanced glycation end-products and progression of airway disease. Iwamoto, Hiroshi; Gao, Jing; Pulkkinen, Ville; Toljamo, Tuula; Nieminen, Pentti; Mazur, Witold // BMC Pulmonary Medicine;2014, Vol. 14 Issue 1, p1 

    Background The receptor for advanced glycation end-products (RAGE) is highly expressed in the lung, where it is believed to have a homeostatic role. Reduced plasma levels of soluble RAGE (sRAGE) have been reported in patients with chronic obstructive pulmonary disease (COPD). The aim of the...

  • Authors' response to Young and Hopkins: vitamin D and lung function. Afzal, Shoaib; Lange, Peter; Bojesen, Stig E.; Freiberg, Jacob J.; Nordestgaard, Børge G. // Thorax;Aug2014, Vol. 69 Issue 8, p770 

    A response from the author of the article "Plasma 25 hydroxyvitamin D, lung function and risk of chronic obstructive pulmonary disease" in the 2014 issue is presented.

  • Pulmonary Function Reduction in Diabetes With and Without Chronic Obstructive Pulmonary Disease. Kinney, Gregory L.; Black-Shinn, Jennifer L.; Wan, Emily S.; Make, Barry; Regan, Elizabeth; Lutz, Sharon; Soler, Xavier; Silverman, Edwin K.; Crapo, James; Hokanson, John E. // Diabetes Care;Feb2014, Vol. 37 Issue 2, p389 

    OBJECTIVE Diabetes damages major organ systems through disrupted glycemic control and increased inflammation. The effects of diabetes on the lung have been of interest for decades, but the modest reduction in pulmonary function and its nonprogressive nature have limited its investigation. A...

  • Steroid Response in Stable Chronic Obstructive Pulmonary Disease. Mendella, L. A.; Manfreda, J.; Warren, C. P. W.; Anthonisen, N. R. // Annals of Internal Medicine;Jan82, Vol. 96 Issue 1, p17 

    Compares a two-week course of methylprednisolone with placebo in a double-blind crossover trial in patients with stable chronic obstructive pulmonary disease. Baseline lung function in patients with chronic obstructive pulmonary disease; Criteria for differentiating patients who respond to...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics